Bookbuilding IPO | ₹500 Cr | Listed at BSE, NSE | Fri, Jul 16, 2021 - Tue, Jul 20, 2021
Tatva Chintan Pharma Chem IPO is a book build issue of ₹500.00 crores. The issue is a combination of fresh issue of 0.21 crore shares aggregating to ₹225.00 crores and offer for sale of 0.25 crore shares aggregating to ₹275.00 crores.
Tatva Chintan Pharma Chem IPO bidding started from Jul 16, 2021 and ended on Jul 20, 2021. The allotment for Tatva Chintan Pharma Chem IPO was finalized on Jul 26, 2021. The shares got listed on BSE, NSE on Jul 29, 2021.
Tatva Chintan Pharma Chem IPO price band is set at ₹1,083 per share. The lot size for an application is 13. The minimum amount of investment required by an retail is ₹14,079 (13 shares) (based on upper price). The lot size investment for sNII is 15 lots (195 shares), amounting to ₹2,11,185, and for bNII, it is 72 lots (936 shares), amounting to ₹10,13,688.
ICICI Securities Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Tatva Chintan Pharma Chem IPO RHP for detailed Information.
IPO Open
Fri, Jul 16, 2021
IPO Close
Tue, Jul 20, 2021
Issue Price
₹1083 per share
Market Cap (Pre-IPO)
₹2,400.48 Cr
| IPO Date | 16 to 20 Jul, 2021 |
| Listed on | Thu, Jul 29, 2021 |
| Face Value | ₹10 per share |
| Price Band | ₹1073 to ₹1083 |
| Issue Price | ₹1083 per share |
| Lot Size | 13 Shares |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 46,16,804 shares (agg. up to ₹500 Cr) |
| Fresh Issue | 20,77,562 shares (agg. up to ₹225 Cr) |
| Offer for Sale | 25,39,242 shares of ₹10 (agg. up to ₹275 Cr) |
| Share Holding Pre Issue | 2,00,87,500 shares |
| Share Holding Post Issue | 2,21,65,062 shares |
| BSE Script Code / NSE Symbol | 543321 / TATVA |
| ISIN | INE0GK401011 |
Tatva Chintan Pharma Chem IPO comprises a total issue size of 46,16,804 shares. Out of which, 23,08,401 (50.00%) are allocated to QIB, 6,92,521 (15.00%) allocated to NII 16,15,882 (35.00%) allocated to RII.
| Investor Category | Shares Offered | % of Total Issue | Max Allottees |
|---|---|---|---|
| QIB Shares Offered | 23,08,401 | 50.00% | NA |
| − Anchor Investor Shares Offered | 13,85,040 | 30.00% | NA |
| − QIB (Ex. Anchor) Shares Offered | 9,23,361 | 20.00% | NA |
| NII (HNI) Shares Offered | 6,92,521 | 15.00% | NA |
| Retail Shares Offered | 16,15,882 | 35.00% | 1,24,298 |
| Total Shares Offered | 46,16,804 | 100.00% |
Investors can bid for a minimum of 13 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 13 | ₹14,079 |
| Retail (Max) | 14 | 182 | ₹1,97,106 |
| S-HNI (Min) | 15 | 195 | ₹2,11,185 |
| S-HNI (Max) | 71 | 923 | ₹9,99,609 |
| B-HNI (Min) | 72 | 936 | ₹10,13,688 |
Tatva Chintan Pharma Chem IPO raises ₹150.00 crore from anchor investors. Tatva Chintan Pharma Chem IPO Anchor bid date is July 15, 2021.
📝 Anchor Investors Letter (PDF)
| Bid Date | Thu, Jul 15, 2021 |
| Shares Offered | 13,85,040 |
| Anchor Portion (₹ Cr.) | 150.00 |
| Anchor lock-in period end date for 50% shares (30 Days) | Wed, Aug 25, 2021 |
| Anchor lock-in period end date for remaining shares (90 Days) | Sun, Oct 24, 2021 |
Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.
The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.
Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.
Competitive strengths
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding capital expenditure requirements for expansion of our Dahej Manufacturing Facility | 147.10 |
| 2 | Funding capital expenditure requirements for upgradation at our R&D facility in Vadodara; and | 23.97 |
| 3 | General corporate purposes | 36.21 |
The Tatva Chintan Pharma IPO is subscribed 180.36 times on July 20, 2021 5:01:00 PM (Day 3). The public issue subscribed 35.35 times in the retail category, 185.23 times in the QIB category, and 512.22 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB | 185.23 | 9,31,966 | 17,26,28,313 |
| NII | 512.22 | 6,98,975 | 35,80,28,073 |
| Retail | 35.35 | 16,30,941 | 5,76,52,010 |
| Total | 180.36 | 32,61,882 | 58,83,08,396 |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | ees payable to the BRLMs and commissions (including underwriting commission, brokerage and selling commission | 19.78 |
| 2 | Selling commission payable to SCSBs for Bids directly procured by them and processing fees payable to SCSBs for Bids (other than Bids submitted by RIIs using the UPI Mechanism) procured by the Members of the Syndicate, the Registered Brokers, CRTAs or CDPsand submitted to SCSBs for blocking, Bankers to the Offer, fees payable to the Sponsor Bank for Bids made by RIBs and Selling commission and uploading charges payable to Members of the Syndicate, RTAs, CDPs and Reg. Brokers | 6.07 |
| 3 | Processing fees payable to the Sponsor Bank | 1.36 |
| 4 | Fees payable to Registrar to the Offer | 0.47 |
| 5 | Printing and stationery expenses | 1.65 |
| 6 | Advertising and marketing expenses | 2.95 |
| 7 | Listing fees, SEBI fees, BSE and NSE processing fees, book-building software fees, and other regulatory expenses | 2.94 |
| 8 | Fees payable to legal counsel | 2.51 |
| Price Details | BSE | NSE |
|---|---|---|
| Final Issue Price | ₹1,083.00 | ₹1,083.00 |
| Open | ₹2,111.80 | ₹2,111.85 |
| Low | ₹2,111.80 | ₹2,111.85 |
| High | ₹2,486.30 | ₹2,534.20 |
| Last Trade | ₹2,310.25 | ₹2,312.20 |
Lead Manager Reports
Tatva Chintan Pharma Chem IPO is a main-board IPO of 46,16,804 equity shares of the face value of ₹10 aggregating up to ₹500 Crores. The issue is priced at ₹1083 per share. The minimum order quantity is 13.
The IPO opens on Fri, Jul 16, 2021, and closes on Tue, Jul 20, 2021.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Tatva Chintan Pharma Chem IPO using UPI as a payment gateway. Zerodha customers can apply in Tatva Chintan Pharma Chem IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Tatva Chintan Pharma Chem IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Tatva Chintan Pharma Chem IPO opens on Fri, Jul 16, 2021 and closes on Tue, Jul 20, 2021.
Tatva Chintan Pharma Chem IPO lot size is 13, and the minimum amount required for application is ₹14,079.
You can apply in Tatva Chintan Pharma Chem IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Tatva Chintan Pharma Chem IPO will be done on Monday, July 26, 2021, and the allotted shares will be credited to your demat account by Wed, Jul 28, 2021. Check the Tatva Chintan Pharma Chem IPO allotment status.
The Tatva Chintan Pharma Chem IPO listing date is on Thu, Jul 29, 2021.
